T1	Participants 109 142	locally advanced cervix carcinoma
T2	Participants 234 287	patients with locally advanced cervical cancer (LACC)
T3	Participants 432 622	Between January 2010 and January 2012, 44 patients with International Federation of Gynecology and Obstetrics (FIGO 2009) stage IIB-IIIB squamous cell carcinoma of the cervix were randomized
